Cure My Disease

Don't miss your cure!

 Log in / Sign up

Greek MS patients monitored on new treatment in Real-World setting

NCT ID NCT06486779

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study observes how well the medication ofatumumab controls multiple sclerosis in real-world medical settings in Greece. It follows 160 adults with relapsing MS who started ofatumumab within the last 5 years of their diagnosis. Researchers will track disease activity, disability progression, and quality of life over 2 years and compare results to standard MS treatments from a previous trial.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS (RMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Alexandroupoli, 681 00, Greece

  • Novartis Investigative Site

    RECRUITING

    Athens, 115 21, Greece

  • Novartis Investigative Site

    RECRUITING

    Athens, 115 25, Greece

  • Novartis Investigative Site

    RECRUITING

    Athens, 115 27, Greece

  • Novartis Investigative Site

    RECRUITING

    Athens, 115 28, Greece

  • Novartis Investigative Site

    ACTIVE_NOT_RECRUITING

    Athens, 145 61, Greece

  • Novartis Investigative Site

    RECRUITING

    Athens, 185 47, Greece

  • Novartis Investigative Site

    RECRUITING

    Chaïdári, 124 62, Greece

  • Novartis Investigative Site

    RECRUITING

    Crete Heraklion, 714 09, Greece

  • Novartis Investigative Site

    RECRUITING

    Ioannina, 455 00, Greece

  • Novartis Investigative Site

    RECRUITING

    Larissa, 411 10, Greece

  • Novartis Investigative Site

    RECRUITING

    Pátrai, 265 04, Greece

  • Novartis Investigative Site

    RECRUITING

    Thessaloniki, 53246, Greece

  • Novartis Investigative Site

    RECRUITING

    Thessaloniki, GR 54636, Greece

Conditions

Explore the condition pages connected to this study.

RELAPSING MULTIPLE SCLEROSIS (RMS)